vault-based coronavirus vaccine

The vault-based coronavirus vaccine is an experimental **nanoparticle biologic vaccine** being developed by Vault Pharma for prevention of COVID-19. It uses genetically engineered **vault nanoparticles**, which are naturally occurring barrel-shaped ribonucleoprotein particles found in human cells, as a delivery platform to package and present **coronavirus proteins** to the immune system. The intended mechanism is to induce both **humoral** and **cellular immune responses** against SARS-CoV-2, with the goal of functioning as a second-generation coronavirus vaccine and potentially also supporting therapeutic immune activation. Based on the provided information, the program remained **preclinical** and had not yet entered human testing.

Other names

vault-based coronavirus vaccinevault-based COVID-19 vaccinevault nanoparticle coronavirus vaccine